Summary
- Current Price
- As of today, ATRA price is $9.69, down -0.21% on
- Current Price All-Time High
- ATRA price is currently -99.41% below its historical high of $1,639.00 set on
- Market Cap
- ATRA current market cap is $97M, up +15.48% over the past 365 days
- Revenue
- ATRA current annual revenue is $120.77M, down -6.33% year-over-year
- Next Earnings
- The next earnings release for ATRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Atara Biotherapeutics, Inc. |
| Ticker | NASDAQ: ATRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | atarabio.com |
| Employees | 89 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $9.69 | ||
| Price, 1D Change | -0.21% | |
| $97M | ||
| - | ||
| - | ||
| 1.21 | ||
| $120.77M | ||
| Revenue, 1Y Change | -6.33% | |
| $2.57 | ||
| EPS, 1Y Change | +122.54% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $2.57 | ||
| EPS Estimate | -$0.95 | N/A |
| EPS Est. Change | -136.96% | N/A |
| $120.77M | ||
| Revenue Estimate | $2.85M | N/A |
| Revenue Est. Change | -97.64% | N/A |
| $9.69 | ||
| Price Target | $13.00 | - |
| Price Tgt. Change | +34.16% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.24 | -$11.41 | -168.99% | |
| $2.79 | $2.57 | -7.88% | |
| -$0.95 | N/A | -136.96% | |
| $1.55 | N/A | -39.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $112.74M | $128.94M | +14.37% | |
| $120.83M | $120.77M | -0.04% | |
| $2.85M | N/A | -97.64% | |
| $40.87M | N/A | -66.16% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -19.72% | ||
| -75.15% | ||
| +15.48% | ||
| -97.53% | ||
| -6.33% | ||
| +89.97% | ||
| +122.54% | ||
| +214.82% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $9.69 | ||
| $8.62 | ||
| $8.93 | ||
| $9.07 | ||
| $9.24 | ||
| $0.19 | ||
| 1.21 | ||
| $0.72 | ||
| 53.57 | ||
| 61.99% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $120.77M | ||
| $2.57 | ||
| $99.56M | ||
| 82.44% | ||
| $49.77M | ||
| 41.21% | ||
| $32.69M | ||
| 27.07% | ||
| $50.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -1.37 | ||
| 0.82 | ||
| 0.82 | ||
| - | ||
| 2 | ||
| -115.47 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 15.70 | ||
| -2.63 | ||
| -9.47 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$38.50M | ||
| $8.48M | ||
| $21.89M | ||
| $12.21M | ||
| $60.39M | ||
| $14.92M | ||
| $52.80M | ||
| $10.78M | ||
| $127.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $88.08M | ||
| $49.79M | ||
| $21.21M | ||
| $0.00 | ||
| $2.12M | ||
| $0.00 | ||
| $31.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$50.94M | ||
| $18.15M | ||
| $16.10M | ||
| $0.00 | ||
| -$50.94M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Freedom Broker | → | |
| Canaccord Genuity | → | |
| Freedom Broker | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| Rodman & Renshaw | ||
| Canaccord Genuity | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ATRA
FAQ
- What is the ticker symbol for Atara Biotherapeutics, Inc.?
- The ticker symbol for Atara Biotherapeutics, Inc. is NASDAQ:ATRA
- Does Atara Biotherapeutics, Inc. pay dividends?
- No, Atara Biotherapeutics, Inc. does not pay dividends
- What sector is Atara Biotherapeutics, Inc. in?
- Atara Biotherapeutics, Inc. is in the Healthcare sector
- What industry is Atara Biotherapeutics, Inc. in?
- Atara Biotherapeutics, Inc. is in the Biotechnology industry
- What country is Atara Biotherapeutics, Inc. based in?
- Atara Biotherapeutics, Inc. is headquartered in United States
- When did Atara Biotherapeutics, Inc. go public?
- Atara Biotherapeutics, Inc. initial public offering (IPO) was on October 16, 2014
- Is Atara Biotherapeutics, Inc. in the S&P 500?
- No, Atara Biotherapeutics, Inc. is not included in the S&P 500 index
- Is Atara Biotherapeutics, Inc. in the NASDAQ 100?
- No, Atara Biotherapeutics, Inc. is not included in the NASDAQ 100 index
- Is Atara Biotherapeutics, Inc. in the Dow Jones?
- No, Atara Biotherapeutics, Inc. is not included in the Dow Jones index
- When was Atara Biotherapeutics, Inc. last earnings report?
- Atara Biotherapeutics, Inc.'s most recent earnings report was on August 12, 2026
- When does Atara Biotherapeutics, Inc. report earnings?
- The next expected earnings date for Atara Biotherapeutics, Inc. is November 12, 2026
Data Sources & References
- ATRA Official Website www.atarabio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1604464/000119312526108361/0001193125-26-108361-index.htm
- ATRA Profile on Yahoo Finance finance.yahoo.com/quote/ATRA
- ATRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atra